Application

15000297 · Eye Drop Formulation

Filed 2016-01-19 · Granted · Patent 9585941 (2017-03-07) The official file ↗The patent and its PDF ↗ · Art unit 1675 · Examiner Roy R Teller Typical · CPC A61K 38/2292 · RegeneRX Biopharmaceuticals, Inc. · ROTHWELL, FIGG, ERNST & MANBECK, P.C.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

2.5 mo

to disposition 13.6 mo

Statutes raised

102 103

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.